A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers (NCT07159282)

🧪 Interventions in This Study

• XWRAP (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Royal Research — Hollywood, Florida

📞 Contact the Study Coordinator

Phone: (833) 865-6300

Email: info@serenagroups.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetic Foot

• Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration — Trois-Rivières, Quebec
• SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II) — Mesa, Arizona
• Effectiveness of Remote Foot Temperature Monitoring — Hines, Illinois
• Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers — Thousand Oaks, California
• Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers — Downey, California

Explore by condition: All Diabetic Foot clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.